Altimmune, Inc.

ALT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 1, 2026
SCHEDULE 13G May 1, 2026
4 May 1, 2026
4 May 1, 2026
SCHEDULE 13G Apr 30, 2026
8-K Apr 24, 2026 FORM 8-K
424B5 Apr 24, 2026 424B5
S-3MEF Apr 22, 2026 S-3MEF
424B5 Apr 22, 2026 424B5
8-K Apr 16, 2026 8-K
4 Apr 6, 2026
4 Apr 1, 2026
4 Apr 1, 2026
SCHEDULE 13G/A Mar 26, 2026
ARS Mar 17, 2026 ARS
DEF 14A Mar 17, 2026 DEF 14A
4 Mar 9, 2026
4 Mar 9, 2026
PRE 14A Mar 6, 2026 PRE 14A
10-K Mar 6, 2026 10-K
8-K Mar 5, 2026 8-K
4 Feb 27, 2026
4 Feb 27, 2026
S-8 Feb 6, 2026 S-8
4 Feb 3, 2026
← Newer Page 2 of 59 · 1458 filings Older →